Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Comparison of Cardiovascular Risk Assessment Tools and Their Guidelines in Evaluation of 10-Year Cvd Risk and Preventive Recommendations: A Population Based Study Publisher Pubmed



Motamed N1 ; Rabiee B2 ; Perumal D3 ; Poustchi H4 ; Miresmail SJH5 ; Farahani B2 ; Maadi M2 ; Saeedian FS2 ; Ajdarkosh H2 ; Khonsari MR2 ; Hemasi GR2 ; Zamani F2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Social Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
  2. 2. Gastrointestinal and Liver Disease Research Center, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran
  3. 3. Faculty of Science, Engineering and Computing, Kingston University, Kingston, United Kingdom
  4. 4. Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Cardiology, Hazrat Rasoul Hospital, Iran University of Medical Sciences, Tehran, Iran

Source: International Journal of Cardiology Published:2017


Abstract

Background Identification of individuals at risk of cardiovascular diseases (CVDs) results in better clinical outcomes and may help policy makers in conscious decision making for community based and national intervention strategies. The main aim of this study was to compare various CVD risk assessment tools and their related guidelines in estimation of 10-year CVD risk and subsequent therapeutic recommendations, respectively. Methods Data of 3086 subjects aged 40–74 years from a cohort study of northern Iran were utilized in this cross-sectional study. The risks were calculated based on American College of Cardiology/American Heart Association (ACC/AHA) tool, two versions of Systematic Coronary Risk Evaluation (SCORE) equations (for low and high risk European countries) and Framingham approach. We also detected participants who ought to be recommended for treatment based on the specific guidelines related to each of the risk assessment tools. Results Mean cardiovascular risks were 12.96%, 8.84%, 1.90% and 3.45% in men and 5.87%, 2.13%, 0.8% and 1.13% in women based on ACC/AHA, Framingham, SCORE equation for low-risk European countries and high-risk European countries, respectively. Based on ACC/AHA, Adult Treatment Panel III (ATPIII) and European Society of Cardiology (ESC) guidelines related to SCORE equations for low and high risk European countries 58.2%, 27.1%, 21.1% and 28.6% of men and 39.7%, 33.0%, 29.5% and 30.7% of women were recommended to statin therapy, respectively. Conclusions In conclusion, more individuals were recommended for treatment by ACC/AHA guideline than the other guidelines. © 2016 Elsevier Ireland Ltd
Related Docs
View other Related Docs
1. Non-Alcoholic Fatty Liver Disease (Nafld) and 10-Year Risk of Cardiovascular Diseases, Clinics and Research in Hepatology and Gastroenterology (2017)
2. The Most Prevalent Causes of Deaths, Dalys, and Geriatric Syndromes in Iranian Elderly People Between 1990 and 2010: Findings From the Global Burden of Disease Study 2010, Archives of Iranian Medicine (2015)
3. Assessment of Serum 25-Hydroxy Vitamin D Improves Coronary Heart Disease Risk Stratification in Patients With Type 2 Diabetes, American Heart Journal (2015)
4. Mean Serum Lipid Levels in Iranian Adult Populations: A Systematic Review and Meta-Analysis, Clinical Lipidology (2015)
5. Evaluation of the Hypercholesterolemia Care Cascade and Compliance With Ncep-Atp Iii Guidelines in Iran Based on the Who Steps Survey, Lipids in Health and Disease (2025)
6. Association Between Nontraditional Risk Factors and Calculated 10-Year Risk of Atherosclerotic Cardiovascular Disease in a Large General Population: Based on the Pars Cohort Study, Journal of Tehran University Heart Center (2023)
7. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 354 Diseases and Injuries for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
8. Comparison of Risk Assessment Tools for Cardiovascular Diseases: Results of an Iranian Cohort Study, Public Health (2021)
Experts (# of related papers)
View all Related Experts
Hossein Poustchi (3)
Farshad Farzadfar (2)
Other Related Docs
9. Burden of Ischemic Heart Disease Attributable to Low Omega-3 Fatty Acids Intake in Iran: Findings From the Global Burden of Disease Study 2010, Journal of Tehran University Heart Center (2016)
10. Pars Risk Charts: A 10-Year Study of Risk Assessment for Cardiovascular Diseases in Eastern Mediterranean Region, PLoS ONE (2017)
11. Discrimination Between Obstructive Coronary Artery Disease and Cardiac Syndrome X in Women With Typical Angina and Positive Exercise Test; Utility of Cardiovascular Risk Calculators, Medicina (Lithuania) (2019)
12. Engineering Natural Heart Valves: Possibilities and Challenges, Journal of Tissue Engineering and Regenerative Medicine (2017)
13. Metabolic Syndrome and Lifestyle-Associated Factors in the Ethnically Diverse Population of Khuzestan, Iran: A Cross-Sectional Study, Journal of Diabetes and Metabolic Disorders (2021)
14. Ada Gene Haplotype Is Associated With Coronary-In-Stent-Restenosis, Molecular Biology Reports (2021)
15. Laboratory-Based and Office-Based Risk Scores and Charts to Predict 10-Year Risk of Cardiovascular Disease in 182 Countries: A Pooled Analysis of Prospective Cohorts and Health Surveys, The Lancet Diabetes and Endocrinology (2017)